Becker's Healthcare August 29, 2024
Jakob Emerson

A federal lawmaker investigating pharmacy benefit managers is accusing top executives from CVS Health, Cigna Group and UnitedHealth Group of making false statements during a committee hearing in July.

On Aug. 28, Rep. James Comer, chair of the House Committee on Oversight and Accountability, called on three PBM executives “to correct the record” regarding testimonies they made during a hearing about how the PBM industry influences prescription drug markets.

“At our hearing, the witnesses claimed they do not steer patients to PBM-owned pharmacies,” the committee wrote on X. “The executives also made claims contradicting the committee’s and FTC’s findings regarding contract negotiations, contract opt outs, and payments to pharmacies.”

Mr. Comer is asking David Joyner, president of CVS Caremark; Adam...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Govt Agencies, Pharma, Pharma / Biotech
Pharma Pulse 11/25/24: Deepening Patient Relationships,
BridgeBio poised to challenge Pfizer after Attruby approval
How Alto Pharmacy Is Redefining the Pharmacy Experience Through Digital Innovation
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry
Survey Suggests Pharma Industry Still Struggling with Digital Transformation

Share This Article